Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DM-AAS aspirin primary cardiovascular prevention study in adults with type 2 diabetes
2008-004387-39Phase 3Active
- Sponsor
- Comunidad de Madrid
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aspirin in atherosclerotic disease (2 arms), sponsored by Comunidad de Madrid. Primary endpoint: Major cardiovascular event. Started Oct 2008; status: active.
02
Drugs
aspirin
03
Conditions
atherosclerotic disease
Beyond the preview
Go deeper on 2008-004387-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004387-39.